686 related articles for article (PubMed ID: 17908254)
1. Comparison of triamcinolone acetonide, 11-deoxycortisol and other lipid formulae for the visualization of vitreous body in the anterior chamber after posterior capsule rupture in animal models.
Kaji Y; Hiraoka T; Okamoto F; Asano H; Oshika T
Acta Ophthalmol; 2008 Feb; 86(1):97-102. PubMed ID: 17908254
[TBL] [Abstract][Full Text] [Related]
2. Visualizing the vitreous body in the anterior chamber using 11-deoxycortisol after posterior capsule rupture in an animal model.
Kaji Y; Hiraoka T; Okamoto F; Sato M; Hu B; Yamane N; Oshika T
Ophthalmology; 2004 Jul; 111(7):1334-9. PubMed ID: 15234133
[TBL] [Abstract][Full Text] [Related]
3. Experimental use of estriol for visualizing the vitreous body in the anterior chamber after posterior capsule rupture in animal models.
Huang R; Kaji Y; Fukuda S; Oshika T
J Cataract Refract Surg; 2009 Jul; 35(7):1260-5. PubMed ID: 19545818
[TBL] [Abstract][Full Text] [Related]
4. Intracameral triamcinolone helps to visualize and remove the vitreous body in anterior chamber in cataract surgery.
Yamakiri K; Uchino E; Kimura K; Sakamoto T
Am J Ophthalmol; 2004 Oct; 138(4):650-2. PubMed ID: 15488797
[TBL] [Abstract][Full Text] [Related]
5. Clinical application of 11-deoxycortisol in visualizing prolapsed vitreous body after posterior capsule rupture in cataract surgery.
Kaji Y; Hiraoka T; Okamoto F; Sato M; Oshika T
J Cataract Refract Surg; 2005 Jun; 31(6):1133-8. PubMed ID: 16039486
[TBL] [Abstract][Full Text] [Related]
6. Visualizing the vitreous.
Thomas R
Ophthalmology; 2005 May; 112(5):946; author reply 946-7. PubMed ID: 15878086
[No Abstract] [Full Text] [Related]
7. Clinical outcomes of combined sutureless vitrectomy with triamcinolone stain to manage vitreous loss resulting from posterior capsule rupture during phacoemulsification.
Chang CJ; Chiang SY; Chen CL; Wang TY
J Cataract Refract Surg; 2006 Dec; 32(12):2054-9. PubMed ID: 17137983
[TBL] [Abstract][Full Text] [Related]
8. Intraocular concentration of triamcinolone acetonide after intravitreal injection in the rabbit eye.
Kamppeter BA; Cej A; Jonas JB
Ophthalmology; 2008 Aug; 115(8):1372-5. PubMed ID: 18355920
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes of triamcinolone-assisted anterior vitrectomy after phacoemulsification complicated by posterior capsule rupture.
Kasbekar S; Prasad S; Kumar BV
J Cataract Refract Surg; 2013 Mar; 39(3):414-8. PubMed ID: 23337526
[TBL] [Abstract][Full Text] [Related]
10. Short-term in vivo evaluation of novel vital dyes for intraocular surgery.
Haritoglou C; Tadayoni R; May CA; Gass CA; Freyer W; Priglinger SG; Kampik A
Retina; 2006; 26(6):673-8. PubMed ID: 16829811
[TBL] [Abstract][Full Text] [Related]
11. Posterior capsule rupture and vitreous loss during phacoemulsification with or without the use of an anterior chamber maintainer.
Androudi S; Brazitikos PD; Papadopoulos NT; Dereklis D; Symeon L; Stangos N
J Cataract Refract Surg; 2004 Feb; 30(2):449-52. PubMed ID: 15030840
[TBL] [Abstract][Full Text] [Related]
12. Postoperative infectious endophthalmitis after triamcinolone-assisted anterior vitrectomy.
Lee SM; Shin YJ; Park KH
J Cataract Refract Surg; 2007 Apr; 33(4):731-2. PubMed ID: 17397751
[TBL] [Abstract][Full Text] [Related]
13. Managing the broken capsule.
Wu MC; Bhandari A
Curr Opin Ophthalmol; 2008 Jan; 19(1):36-40. PubMed ID: 18090896
[TBL] [Abstract][Full Text] [Related]
14. Persistent triamcinolone acetonide particles on the posterior lens capsule after intravitreal injection.
Sakalar YB; Unlu K; Keklikci U; Caca I; Senol BB
Ann Ophthalmol (Skokie); 2008; 40(3-4):190-2. PubMed ID: 19230363
[TBL] [Abstract][Full Text] [Related]
15. Outcome of paediatric cataract surgery with primary posterior capsulotomy and anterior vitrectomy using intra-operative preservative-free triamcinolone acetonide.
Gupta R; Ram J; Sukhija J; Singh R
Acta Ophthalmol; 2014 Aug; 92(5):e358-61. PubMed ID: 24730623
[TBL] [Abstract][Full Text] [Related]
16. A rabbit model for assessing the ocular barriers to the transscleral delivery of triamcinolone acetonide.
Robinson MR; Lee SS; Kim H; Kim S; Lutz RJ; Galban C; Bungay PM; Yuan P; Wang NS; Kim J; Csaky KG
Exp Eye Res; 2006 Mar; 82(3):479-87. PubMed ID: 16168412
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of triamcinolone acetonide following intravitreal injection in New Zealand white rabbits.
McGee DH; Dembinska O; Gruebbel MM
Int J Toxicol; 2005; 24(6):419-25. PubMed ID: 16393934
[TBL] [Abstract][Full Text] [Related]
18. Intracameral triamcinolone helps to visualize and remove the vitreous body in anterior chamber in cataract surgery.
Singh DV; Pal N; Sharma YR; Azad RV
Am J Ophthalmol; 2005 Apr; 139(4):756; author reply 756. PubMed ID: 15808207
[No Abstract] [Full Text] [Related]
19. [Efficacy of intravitreal triamcinolone acetonide in the visualization of the vitreous during pars plana vitrectomy].
Mańkowska A; Rejdak R; Nowomiejska K; Zagórski Z
Klin Oczna; 2006; 108(1-3):24-7. PubMed ID: 16883934
[TBL] [Abstract][Full Text] [Related]
20. Safety and pharmacodynamics of suprachoroidal injection of triamcinolone acetonide as a controlled ocular drug release model.
Chen M; Li X; Liu J; Han Y; Cheng L
J Control Release; 2015 Apr; 203():109-17. PubMed ID: 25700623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
